Oxford Covid Vaccine Draws Immune Response Among Young, Old: AstraZeneca
World News | Reuters | Monday October 26, 2020
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca Plc said on Monday.
UK Hospital Told To Prepare For Oxford COVID Vaccine In November: Report
World News | Reuters | Monday October 26, 2020
Staff at a major London hospital trust have been told to be ready to receive the first batches of the vaccine being developed by the University of Oxford and AstraZeneca Plc, The Sun newspaper reported on Monday.
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
World News | Agence France-Presse | Saturday September 12, 2020
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
India News | Press Trust of India | Monday August 3, 2020
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
Panel Recommends Oxford COVID Vaccine Partner For Phase 2,3 Human Trial
India News | Press Trust of India | Saturday August 1, 2020
A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
India News | Press Trust of India | Monday July 27, 2020
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
Oxford Vaccine Partner Plans Trials In India, Manufacturing Soon
India News | Edited by Anindita Sanyal | Tuesday July 21, 2020
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK.
COVID-19 Vaccine Likely By September, Says Indian Firm Partnering Oxford
India News | Reported by Nidhi Razdan, Edited by Anindita Sanyal | Tuesday April 28, 2020
A vaccine for coronavirus may be available in the market as early as the end of September, the chief of the world's largest vaccine maker has told NDTV.
Oxford Covid Vaccine Draws Immune Response Among Young, Old: AstraZeneca
World News | Reuters | Monday October 26, 2020
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca Plc said on Monday.
UK Hospital Told To Prepare For Oxford COVID Vaccine In November: Report
World News | Reuters | Monday October 26, 2020
Staff at a major London hospital trust have been told to be ready to receive the first batches of the vaccine being developed by the University of Oxford and AstraZeneca Plc, The Sun newspaper reported on Monday.
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
World News | Agence France-Presse | Saturday September 12, 2020
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial
India News | Press Trust of India | Monday August 3, 2020
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country.
Panel Recommends Oxford COVID Vaccine Partner For Phase 2,3 Human Trial
India News | Press Trust of India | Saturday August 1, 2020
A subject expert committee on COVID-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.
India Readies 5 Sites For Final Phase Of Human Trials Of Oxford COVID Vaccine
India News | Press Trust of India | Monday July 27, 2020
Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Secretary of Department of Biotechnology (DBT) Renu Swarup said on Monday.
Oxford Vaccine Partner Plans Trials In India, Manufacturing Soon
India News | Edited by Anindita Sanyal | Tuesday July 21, 2020
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK.
COVID-19 Vaccine Likely By September, Says Indian Firm Partnering Oxford
India News | Reported by Nidhi Razdan, Edited by Anindita Sanyal | Tuesday April 28, 2020
A vaccine for coronavirus may be available in the market as early as the end of September, the chief of the world's largest vaccine maker has told NDTV.
................................ Advertisement ................................
................................ Advertisement ................................
